Suppr超能文献

群体免疫:韩国面临的挑战与前进道路。

Herd immunity: challenges and the way forward in Korea.

机构信息

Division of Risk Assessment, Korea Disease Control and Prevention Agency, Cheongju, Korea.

出版信息

Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.

Abstract

Vaccination is considered to be the most effective measure for preventing the spread of coronavirus disease 2019 (COVID-19). Many countries, including of Korea, are focusing on achieving herd immunity with the goal of reaching a vaccination rate of 70-80%. However, achieving herd immunity does not mean eradicating COVID-19, and the following challenges can occur in the process of achieving herd immunity. First, as the vaccination rate is likely to slow down over time, it is necessary to promote the benefits of vaccination through risk communication strategies and provide incentives for those who have been vaccinated. Second, a booster dose may be required depending on future studies on vaccine-induced immunity. Third, since variants capable of evading immunity and with higher transmissibility can emerge, rapid contract tracing and regular community genomic surveillance could help mitigate the impact of new variants. When the impact of COVID-19 is controlled to the level of seasonal influenza, the current public health measures that have been strictly imposed on society since the beginning of the pandemic will no longer be needed. The overall response strategy to COVID-19 will need to change accordingly, based on evaluations of the level of population immunity. These changes will include more efficient and targeted contact tracing and eased quarantine measures for vaccinated close contacts and travelers. Mask wearing and a minimum of social distancing will still be required in the journey towards the end of the pandemic. The COVID-19 pandemic will end, but the virus will not disappear.

摘要

接种疫苗被认为是预防 2019 年冠状病毒病(COVID-19)传播的最有效措施。包括韩国在内的许多国家都专注于通过达到 70-80%的疫苗接种率来实现群体免疫。然而,实现群体免疫并不意味着消灭 COVID-19,在实现群体免疫的过程中可能会出现以下挑战。首先,随着时间的推移,疫苗接种率可能会放缓,因此有必要通过风险沟通策略来宣传疫苗接种的好处,并为已接种疫苗的人提供激励。其次,根据未来关于疫苗诱导免疫的研究,可能需要加强针。第三,由于可能逃避免疫且具有更高传染性的变异株的出现,快速接触者追踪和定期社区基因组监测可以帮助减轻新变异株的影响。当 COVID-19 的影响控制到季节性流感的水平时,自大流行开始以来严格强加给社会的当前公共卫生措施将不再需要。基于对人群免疫水平的评估,需要相应地改变对 COVID-19 的整体应对策略。这些变化将包括更有效和有针对性的接触者追踪,以及放宽对已接种疫苗的密切接触者和旅行者的隔离措施。在大流行结束的过程中,仍然需要戴口罩和保持最小的社交距离。COVID-19 大流行将会结束,但病毒不会消失。

相似文献

1
Herd immunity: challenges and the way forward in Korea.群体免疫:韩国面临的挑战与前进道路。
Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.
2
Lockdowns and the COVID-19 pandemic: What is the endgame?封锁和 COVID-19 大流行:结局是什么?
Scand J Public Health. 2021 Feb;49(1):37-40. doi: 10.1177/1403494820961293. Epub 2020 Sep 26.
3
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.实现美国 COVID-19 疫苗衍生群体免疫阈值
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.

本文引用的文献

6
How did Sweden Fail the Pandemic?瑞典在这场疫情中是如何失利的?
Int J Health Serv. 2021 Oct;51(4):417-422. doi: 10.1177/0020731421994848. Epub 2021 Feb 26.
10
Antibody response to SARS-CoV-2 infection in humans: A systematic review.人类对 SARS-CoV-2 感染的抗体反应:系统综述。
PLoS One. 2020 Dec 31;15(12):e0244126. doi: 10.1371/journal.pone.0244126. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验